Latest Views & analysis
While many of the hopes and disappointments for AZ’s business are around oncology, it still needs its cardiovascular and diabetes portfolio to perform.
How big data and patient centricity are changing the Medical Affairs function.
More Views & Analysis
Hanno Wolfram puts the case for digitalisation in the German health sector.
How can orphan drug manufacturers demonstrate value and improve access to drugs?
Status of immunotherapies in non-small cell lung cancer (NSCLC).
Can reducing NHS spending on ‘low-value’ prescriptions help fund new drugs?
Tackling antimicrobial drug resistance with calorimetry.